Drugs Made In America Acquisition II Corp.

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Entry into a Material Definitive Agreement

Annual report pursuant to Section 13 or 15(d)

Entry into a Material Definitive Agreement

Notification of late filing of Form 10-K

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

General form for quarterly reports under Section 13 or 15(d)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Notification of late filing of Form 10-Q

Other Events

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Entry into a Material Definitive Agreement

Prospectus Supplement with Pricing Information

Registration of Securities on Exchange

Certification of approval for listing and registration on a national securities exchange

Notice of Effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Amended Initial Registration Statement

Letter from the SEC

Amended Initial Registration Statement

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission)

Do Catherine

Shulgan Myron W.

Drugs Made In America Acquisition II LLC

Stockwell Lynn

Prasad Sridhar G.

Worman Glenn C.

Drugs Made In America Acquisition II LLC

Shulgan Myron W.

Worman Glenn C.

Stockwell Lynn

Prasad Sridhar G.

Do Catherine